Dental management of scleroderma patients using pentoxifylline plus vitamin E with and without TheraBite® to reduce trismus: Two case reports and brief review of literature
- PMID: 32128166
- PMCID: PMC7044382
- DOI: 10.1002/ccr3.2572
Dental management of scleroderma patients using pentoxifylline plus vitamin E with and without TheraBite® to reduce trismus: Two case reports and brief review of literature
Abstract
To provide evidence supporting the off label use of pentoxifylline and vitamin E especially by dentists with TheraByte to reduce trismus in scleroderma patients.
Keywords: Thera Bite®; VitE; pentoxifylline; scleroderma; trismus.
© 2019 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
Conflict of interest statement
There were no conflicts of interest or external funding sources to disclose.
Similar articles
-
A pilot study of pentoxifylline in the treatment of radiation-induced trismus.Am J Clin Oncol. 2001 Aug;24(4):366-9. doi: 10.1097/00000421-200108000-00010. Am J Clin Oncol. 2001. PMID: 11474263 Clinical Trial.
-
Exercise adherence in patients with trismus due to head and neck oncology: a qualitative study into the use of the Therabite.Int J Oral Maxillofac Surg. 2009 Sep;38(9):947-54. doi: 10.1016/j.ijom.2009.04.003. Epub 2009 May 2. Int J Oral Maxillofac Surg. 2009. PMID: 19414238
-
Impact of exercise with TheraBite device on trismus and health-related quality of life: A prospective study.Ear Nose Throat J. 2020 Oct 9:145561320961727. doi: 10.1177/0145561320961727. Online ahead of print. Ear Nose Throat J. 2020. PMID: 33035128
-
Role of pentoxifylline and vitamin E in attenuation of radiation-induced fibrosis.Ann Pharmacother. 2005 Mar;39(3):516-22. doi: 10.1345/aph.1E186. Epub 2005 Feb 8. Ann Pharmacother. 2005. PMID: 15701781 Review.
-
The role of pentoxifylline as a modifier of radiation therapy.Cancer Treat Rev. 2005 Oct;31(6):448-55. doi: 10.1016/j.ctrv.2005.07.007. Epub 2005 Oct 12. Cancer Treat Rev. 2005. PMID: 16225996 Review.
Cited by
-
A Review of Oral Chronic Graft-Versus-Host Disease: Considerations for dental hygiene practice.J Dent Hyg. 2022 Apr;96(2):6-17. J Dent Hyg. 2022. PMID: 35418491 Free PMC article. Review.
-
Oral Chronic Graft-Versus-Host Disease: Pathogenesis, Diagnosis, Current Treatment, and Emerging Therapies.Int J Mol Sci. 2024 Sep 27;25(19):10411. doi: 10.3390/ijms251910411. Int J Mol Sci. 2024. PMID: 39408739 Free PMC article. Review.
References
-
- deSouza RBC, Macedo AR, Kuruma KA, Macedo PA. Pentoxifylline in association with vitamin E reduces cutaneous fibrosis in systemic sclerosis. Clin Rheumatol. 2009;28:1207‐1212. - PubMed
-
- Fischer DJ, Patton LL. Scleroderma: oral manifestations and treatment challenges. Spec Care Dent. 2000;20:240‐244. - PubMed
-
- Mayes MD, Lacey JV, Beebe‐Dimmer J, Gillespie BW. Prevalence, incidence, survival and disease characteristics of systemic sclerosis in a large US population. Arthritis & Rheum. 2003;48:2246‐2255. - PubMed
-
- Hachulla E, Launay D. Diagnosis and classification of systemic sclerosis. Clin Rev Allergy Immunol. 2011;40:78‐83. - PubMed
-
- Schumacher HR Jr, Kippel JH, Robinson DR, eds. Systemic sclerosis and localized scleroderma In: Primer on Rheumatic Diseases (9th edn). Atlanta, GA: Arthritis Foundation; 1988;111‐117.
Publication types
LinkOut - more resources
Full Text Sources